Details for Patent: 9,850,246
✉ Email this page to a colleague
Which drugs does patent 9,850,246 protect, and when does it expire?
Patent 9,850,246 protects QULIPTA and is included in one NDA.
This patent has three patent family members in two countries.
Summary for Patent: 9,850,246
Title: | Process for making CGRP receptor antagonists |
Abstract: | The invention encompasses a novel process for making piperidinone carboxamide indane and azainane derivatives, which are CGRP receptor antagonists useful for the treatment of migraine. |
Inventor(s): | Chen; Frank (Plainsboro, NJ), Molinaro; Carmela (Colonia, NJ), Wuelfing; W. Peter (Harleysville, PA), Yasuda; Nobuyoshi (Mountainside, NJ), Yin; Jianguo (Plainsboro, NJ), Zhong; Yong-Li (Edison, NJ), Lynch; Joseph (Plainsboro, NJ), Andreani; Teresa (Matawan, NJ) |
Assignee: | MERCK SHARP & DOHME CORP. (Rahway, NJ) |
Application Number: | 14/854,760 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 9,850,246
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | QULIPTA | atogepant | TABLET;ORAL | 215206-001 | Sep 28, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Abbvie | QULIPTA | atogepant | TABLET;ORAL | 215206-002 | Sep 28, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
Abbvie | QULIPTA | atogepant | TABLET;ORAL | 215206-003 | Sep 28, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,850,246
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2849568 | ⤷ Try a Trial | |||
European Patent Office | 3430906 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 2013169348 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |